Biogen (BIIB)

Accounts Payable

$403.90M

Quarterly · Period ending: · USD

BIIB logo

BIIB Accounts Payable

Latest reported$403.90M
BIIB Quarterly Accounts Payable ($0.00 → $403.90M)
High-resolution chart · PNG

BIIB accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
403,900,000
358,500,000
432,000,000
413,100,000
408,400,000
391,500,000
424,200,000
422,700,000
354,500,000
387,000,000
403,300,000
440,100,000
445,400,000
491,200,000
491,500,000
383,200,000
434,800,000
398,700,000
589,200,000
427,900,000
375,300,000
430,400,000
454,900,000
398,400,000
383,900,000
389,000,000
459,400,000
382,200,000
377,100,000
378,000,000
370,500,000
342,300,000
295,700,000
345,800,000
395,500,000
298,700,000
330,300,000
316,400,000
279,800,000
274,000,000
225,900,000
271,300,000
267,400,000
251,228,000
282,702,000
236,128,000
229,200,000
233,629,000
224,931,000
212,809,000
219,913,000
166,709,000
163,094,000
165,207,000
203,999,000
157,424,000
159,152,000
173,330,000
186,448,000
159,197,000
170,746,000
159,136,000
162,529,000
143,699,000
144,476,000
121,356,000
118,534,000
108,547,000
210,941,000
104,271,000
107,417,000
123,512,000
116,755,000
114,842,000
90,672,000
92,336,000
99,440,000
102,183,000
100,457,000
62,822,000
62,280,000
58,119,000
99,780,000
48,210,000
66,004,000
75,015,000
121,471,000
77,493,000
85,817,000
78,382,000
63,364,000
34,345,000
31,924,000
42,317,000
3,886,000
43,442,000
59,682,000
42,186,000
50,944,000
46,482,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.